Search filters

List of works by Francois Delhommeau

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

scientific article (publication date: 28 April 2005)

Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms

scientific article published on 29 June 2009

Applying ecological and evolutionary theory to cancer: a long and winding road

scientific article published on 16 November 2012

Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism

scientific article published on 17 April 2017

Clonal architecture of chronic myelomonocytic leukemias

scientific article published on 14 January 2013

Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy

scientific article published on 24 June 2020

Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation.

scientific article

Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis.

scientific article

Elliptocytosis in patients with C-terminal domain mutations of protein 4.1 correlates with encoded messenger RNA levels rather than with alterations in primary protein structure.

scientific article

Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis.

scientific article published on 5 September 2006

Genetic Hierarchy of Acute Myeloid Leukemia: From Clonal Hematopoiesis to Molecular Residual Disease

scientific article published on 03 December 2018

Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders

scientific article published on 14 March 2006

Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia.

scientific article published on 18 August 2016

Interest of cytogenetic and FISH evaluation for prognosis evaluation in 198 patients with acute myeloid leukemia in first complete remission in a single institution

scientific article published on 04 June 2014

Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia.

scientific article published on 7 March 2016

JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines.

scientific article

Macrophage migration inhibitory factor is overproduced through EGR1 in TET2<sup>low</sup> resting monocytes

scientific article published on 03 February 2022

Measurement of telomere length on tissue sections using quantitative fluorescencein situ hybridization (Q-FISH)

scientific article published on 01 August 2003

Molecular aspects of myeloproliferative neoplasms.

scientific article published on 27 February 2010

Mutations du gèneTET2dans les hémopathies myéloïdes humaines

article

Natural history of hereditary spherocytosis during the first year of life

scientific article published on 01 January 2000

New mutations and pathogenesis of myeloproliferative neoplasms.

scientific article published on 07 June 2011

Nonsense-mediated mRNA decay (NMD) blockage promotes nonsense mRNA stabilization in protein 4.1R deficient cells carrying the 4.1R Coimbra variant of hereditary elliptocytosis

scientific article published on September 21, 2010

Oncogenic kinases of myeloproliferative disorders induce both protein synthesis and G1 activators

scientific article published on 10 August 2006

Persistent maternal viremia after varicella infection during pregnancy as a possible cause of false positive prenatal diagnosis of fetal infection on amniotic fluid

scientific article published on 01 August 2004

Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia

scientific article

Primary plasma cell leukemia mimicking an adult T-cell leukemia-lymphoma: a case report.

scientific article

Protein 4.1R expression in normal and dystrophic skeletal muscle.

scientific article published on January 2005

Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis.

scientific article published in January 2000

Reed Sternberg cell/lymphocyte rosettes in a bone marrow aspirate leading to the diagnosis of Hodgkin lymphoma.

scientific article

Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death.

scientific article published on December 2003

Role of TET2 mutations in myeloproliferative neoplasms

scientific article published on 01 March 2012

Sensitivity to Radiation and Alkylating Agent of Peripheral Lymphocytes and Fibroblasts in a Hoyeraal-Hreidarsson Syndrome Patient

scientific article published on December 1, 2003

TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis

TET2 deficiency inhibits mesoderm and hematopoietic differentiation in human embryonic stem cells.

scientific article published on August 2014

TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis

scientific journal article

TP53 mutations: the dawn of Shwachman clones

scientific article

Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant

scientific article published on 01 November 2002

Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.

scientific article

The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera

scientific article published on 27 March 2007

The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues

scientific article

The cell cycle regulator CDC25A is a target for JAK2V617F oncogene.

scientific article published on 7 November 2011

The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity

scientific article published on 08 July 2008

Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.

scientific article published on 11 December 2009